Canadian Reimbursement Trends and Timelines Report

April 2020 Update

Market access professionals needmeaningful insights.

The Canadian Reimbursement Trends and Timelines Report is a credible, relevant and comprehensive resource that provides actionable market access intelligence.

FEEDBACK ON THIS REPORT

WHAT IS THIS REPORT?

The Canadian Reimbursement Trends and Timelines Report April 2020 update is a 50+ page PowerPoint resource of analysis and insights from trusted industry experts.

WHO WOULD BENEFIT?

Market access professionals interested in the Canadian market.

WHY THIS REPORT?

MORSE analyzed Canadian market access data to create key reimbursement metrics.  The Report can support any organization planning a Canadian launch by providing key metrics on the public market reimbursement process – from HTA submission, all the way to provincial listing.

WHAT DOES THE REPORT INCLUDE?

  • pCPA Developments
  • CADTH and pCPA volume metrics
  • Analysis of pCPA process phase timelines
  • Negotiation trends
  • Provincial time-to-listing trends and market access timelines
    • Including a sub-analysis with stratification by oncology & non-oncology

WHAT TIME PERIOD DOES IT COVER?

The Report focuses on metrics from 2019 but also provides relevant comparison to 2018 and 2017 to identify trends. In addition, it contains formulary listing dates of 2018 & 2019 pCPA Completed Negotiations current as of April 1, 2020.

For further information on content and pricing, please complete the form below.


We're committed to your privacy. MORSE may use the information you provide to us to contact you about our relevant content and services. Your name, address and all other personal information will not be sold or given to any other organization or list distributor. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

Canadian Reimbursement Trends and Timelines Report, April 2020 Update
css.php